"In all 11 ArcView meetings, I have never seen our investors react more unfavorably to a company than they reacted to CEN Biotech (FIT*).
Troy Dayton, CEO of Arcview (via email)
This isn't a good indicator of how he did.
Personally I will give bill a chance but his past is awful. I just don't like the association and Sterling standing next to him WHILE arcview looked at them in a negative light.